日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Use of a Personalized Clinical Decision Support System for Dosing in Psychopharmacotherapy in Patients with Alcoholic Hallucinosis Based on Pharmacogenomic Markers

基于药物基因组学标记的酒精性幻觉症患者精神药物治疗剂量个性化临床决策支持系统的应用

Skryabin, VYu; Petukhov, A E; Pozdniakov, S A; Ivanchenko, V A; Zaytsev, I A; Miroshkin, S S; Sokolova, S I; Bure, I V; Smirnov, V V; Sychev, D A

Relationship of the 1846G > A Polymorphism of the CYP2D6 Gene to the Equilibrium Concentration Levels of Haloperidol in Patients with Acute Alcoholic Hallucinosis

CYP2D6基因1846G>A多态性与急性酒精性幻觉患者体内氟哌啶醇平衡浓度水平的关系

Parkhomenko, A A; Zastrozhin, M S; Skryabin, VYu; Petukhov, A E; Pozdniakov, S A; Ivanchenko, V A; Zaytsev, I A; Bure, I V; Bochkov, P O; Akmalova, K A; Smirnov, V V; Bryun, E A; Sychev, D A

Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis

CYP3A4*1B单核苷酸多态性与氟哌啶醇治疗急性酒精性幻觉症患者的疗效和安全性之间的关系

Parkhomenko, A A; Zastrozhin, M S; Skryabin, VYu; Petukhov, A E; Pozdniakov, S A; Ivanchenko, V A; Zaytsev, I A; Bure, I V; Bochkov, P O; Akmalova, K A; Smirnov, V V; Bryun, E A; Sychev, D A

Consequences of 1,4-Butanediol Misuse: A Review

1,4-丁二醇滥用的后果:综述

Skryabin, VYu; Shevtsova, YuB; Novoselova, E A

Influence of CYP2C19*17 Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive Disorder

CYP2C19*17基因多态性对复发性抑郁症患者艾司西酞普兰稳态浓度的影响

Zastrozhin, M S; Skryabin, VYu; Rwere, F; Petukhov, A E; Pankratenko, E P; Pozdniakov, S A; Ivanchenko, V A; Noskov, V V; Zaytsev, I A; Vinokurova, N V; Horyaev, D S; Vlasovskih, R V; Bryun, E A; Sychev, D A

Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses

CYP2D6基因1846G>A多态性与酒精性幻觉患者使用氟哌啶醇的疗效和安全性的相关性

Parkhomenko, A A; Zastrozhin, M S; Skryabin, VYu; Ivanchenko, V A; Pozdniakov, S A; Noskov, V V; Zaytsev, I A; Denisenko, N P; Akmalova, K A; Bryun, E A; Sychev, D A

Association of CYP2D6*4 Polymorphism with the Steady-State Concentration of Haloperidol in Patients with Alcohol-Induced Psychotic Disorders

CYP2D6*4多态性与酒精性精神病患者体内氟哌啶醇稳态浓度的相关性

Parkhomenko, A A; Zastrozhin, M S; Pozdnyakov, S A; Noskov, V V; Zaytsev, I A; Ivanchenko, V A; Denisenko, N P; Akmalova, K A; Skryabin, VYu; Bryun, E A; Sychev, D A

Influence of Plasma Concentration of Hsa-Mir-370-3p and Cyp2d6*4 On Equilibrium Concentration of Phenazepam in Patients with Recurrent Depressive Disorder

血浆中 Hsa-Mir-370-3p 和 Cyp2d6*4 浓度对复发性抑郁症患者苯那西泮平衡浓度的影响

Zastrozhin, M S; Efimova, A V; Skryabin, VYu; Smirnov, V V; Petukhov, A E; Pankratenko, E P; Pozdniakov, S A; Kaverina, E V; Klepikov, D A; Grishina, E A; Ryzhikova, K A; Bure, I V; Bryun, E A; Sychev, D A

Impact of the Omics-Based Biomarkers on the Mirtazapine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder

组学生物标志物对伴有酒精使用障碍的情感障碍患者米氮平稳态浓度、疗效和安全性的影响

Zastrozhin, M S; Skryabin, VYu; Smirnov, VYu; Zastrozhina, A K; Kaverina, E V; Klepikov, D A; Grishina, E A; Ryzhikova, K A; Bure, I V; Bryun, E A; Sychev, D A

Impact of the Omics-Based Biomarkers on the Fluvoxamine's Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder

组学生物标志物对氟伏沙明在合并酒精使用障碍的情感障碍患者中的稳态浓度、疗效和安全性的影响

Zastrozhin, M S; Skryabin, VYu; Smirnov, VYu; Zastrozhina, A K; Kaverina, E V; Klepikov, D A; Grishina, E A; Ryzhikova, K A; Bure, I V; Bryun, E A; Sychev, D A